EPO and chronic kidney disease: Although relative erythropoietin (EPO) deficiency and disordered iron metabolism are the major mechanisms of anemia of CKD, uremia-induced circulating inhibitors of erythropoiesis have also been reported to play some role in this disorder [3–6].